Drug Name: | Alogliptin |
---|---|
Drug Class: | Dipeptidyl peptidase-4 (DPP-4) inhibitor |
Mechanism of Action: | Inhibits the enzyme DPP-4, which increases the levels of incretin hormones (GLP-1 and GIP), leading to increased insulin secretion and decreased glucagon secretion |
Use: |
|
Side Effects: |
|
Contraindications: |
|
Specialty: |
|